In our webinar, Cas-CLOVER: A Clean Alternative to CRISPR,” two experts present data on Cas-CLOVER fundamentals such as architecture, design and implementation in cells, yeast, plants as well as advanced gene editing in human T-cells for allogeneic CAR-T therapies. Thanks to GEN: Genetic Engineering and Biotechnology News for hosting.
To learn more information about Cas-CLOVER technology, reach out to us today.
